|
Clare Hastings, PhD, RN, FAAN Chief Nursing and Patient Care Service
|
Clare Hastings is currently Chief for Nursing and Patient Care Services at the NIH Clinical Center in Bethesda, Maryland. She directs patient care services that support intramural research activities conducted by the National Institutes of Health at its 242-bed research hospital and ambulatory care facility in Bethesda, Maryland and serves as Chief Nurse Officer, responsible for overall nursing practice at the Clinical Center. She also directs the nursing research program at the Clinical Center with portfolio strengths in health behavior, quality of life, symptom management, health disparities reduction and applied clinical research.
Dr. Hastings started her career as a staff nurse at the Clinical Center, and has held senior management roles at the Washington Hospital Center, in Washington, DC and the University of Maryland Medical System in Baltimore, Maryland. Since returning to the NIH in 2000, she has put significant effort into development of a thriving nursing research program that is integrated with clinical care delivery and supports research involvement by nurses at all stages of career growth. Dr. Hastings is past president of the American Academy of Ambulatory Care Nursing where she became nationally known as a spokesperson for defining the role and contributions of nurses in ambulatory care. She has extensive publications and presentations on ambulatory care nursing, professional practice development and nursing administration. She also has a long-standing affiliation with the University of Maryland School of Nursing where she has taught graduate level courses in measurement and research methodology. Dr. Hastings has a BA in Anthropology from Reed College, a BS in Nursing from the University of Maryland, an MS in Nursing Administration from Georgetown University, and a PhD in Nursing from the University of Maryland. |
|
Gwenyth R. Wallen, PhD, RN
Section Chief, Research and Practice Development Service |
Gwenyth Wallen is currently the Chief of the Research and Practice Development Service. Her clinical research specializations include health behavior and health disparities research with special emphasis on methodology and measurement in vulnerable populations. Prior to beginning her career as a clinical nurse scientist she held advance practice roles as the Clinical Specialist for Neonatology and Clinical Manager of the Level III NICU at the Washington Hospital Center, in Washington, DC. Dr. Wallen also served as a post-doctoral research associate in the Department of Family Studies at the University of Maryland coordinating evaluation research for three state and local Responsible Fatherhood programs. She began her career as a staff nurse in Pediatric Oncology at the NIH Clinical Center in 1980.
Dr. Wallen is a member of the NICHD Institutional Review Board. She is also currently serving as an Adjunct Assistant Professor at Georgetown University School of Nursing and Health Studies where she teaches a graduate level course in measurement and research methodology. Dr. Wallen has a BS in Nursing from the University of Maryland, a MA in Management and Supervision from Central Michigan University, and a PhD in Health Education from the University of Maryland.
Current research activities:
Principal Investigator: 02-CC-0053 A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention.
Associate Investigator: 02-CC-0146 A Pilot Study Evaluating the Assessment Process for Constipation in Pediatric Oncology Patients Who are Receiving Vinca Alkaloids and/or Narcotics.
Principal Investigator: 03-CC-0301 Health Beliefs and Health Behavior Practices, Including Complementary and Alternative Medicine Use, Among Minorities with Rheumatic Disease.
Associate Investigator: 04-CC-0070 Exploring Patient-Provider Trust Among Individuals with End-Stage Renal Disease |
|
Margaret F. Bevans PhD, RN, AOCN
Clinical Nurse Specialist, Research |
Margaret Bevans is a Clinical Nurse Specialist in Research within the Research and Practice Development Service of the Clinical Center Nursing Department at the National Institutes of Health (NIH).
Dr. Bevans received her B.S. from Johns Hopkins University in Baltimore, Maryland in 1986 and started her career at the NIH in 1988. She began working in Hematology & Blood and Marrow Transplantation (BMT) in 1992. Dr. Bevans’ graduate education was at the University of Maryland receiving her MS in 1993 and her PhD in 2005. Dr. Bevans has received the Josh Gottheil Memorial BMT Career Development award from the Oncology Nursing Society in addition to a NIH Directors award for her continued efforts to improve the practice of BMT. She is currently the chair of the BMT Intramural Consortium Coordinating committee, coordinator of the ONS BMT SIG (2006 – 2007), and has been a member of the National Heart, Lung, and Blood IRB since 1997.
Current research activities:
Principal Investigator: 00-CC-0002 Quality of Life in Patients Undergoing a Non-Myeloablative versus a Myeloablative Allogeneic PBSC Transplant for Hematological Diseases.
Principal Investigator (Dissertation Research) The Influence of Social and Psychological Variables on Morbidity and Mortality Following Allogeneic Stem Cell Transplantation
Co-Principal Investigator: 05-CC-0216 Prospective Study of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation |
|
Sandra A. Mitchell, PhD, CRNP, AOCN
|
Sandra Mitchell is a Senior Research Nurse Specialist, National Institutes of Health, and an Oncology Nurse Practitioner with the Multidisciplinary Chronic Graft Versus Host Disease (GvHD) Clinic and Study Group, National Cancer Institute.
She received her PhD from the University of Utah, College of Nursing, and undergraduate and master’s degrees from the University of Toronto and the University of Rochester. Her research focuses on efforts to improve the quality of rehabilitation provided during and following cancer treatment and emphasizes three areas: (1) characterizing the impact of symptom burden on functional status (both self-report and performance-based measures of functional status), (2) development and testing of self-management interventions for long-term survivors of allogeneic HSCT experiencing chronic graft-versus-host disease, and (3) evaluation of interventions to prevent or attenuate fatigue, disordered sleep, and functional decline as individual symptoms and as a symptom cluster, in patients with cancer. Methodologic and programmatic interests that cross-cut these research emphases include the use of mixture modeling data analytic approaches, performance-based measures of functional status, fatigue, and sleep quality (eg. walk distance, grip strength, body bug, night cap, actigraphy), and implementation science.
The author of more than 50 publications in the areas of hematopoietic stem cell transplantation, symptom management, functional status, cancer survivorship, and role development in advanced practice nursing, she is also a member of the adjunct faculty at the University of Maryland School of Nursing, Baltimore, MD.
In 2006, her working in cancer survivorship was recognized with a National Institutes of Health, Clinical Center Director’s Award for Science.
Current research activities:
Co-Principal Investigator: 5-CC-0216, Prospective Study of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation
Associate Investigator: 04-C-0281, Prospective Assessment of Clinical and Biological Factors Determining Outcomes in Patients with Chronic Graft-Versus-Host Disease
Principal Investigator: Modeling the Relationships Among Functional Status, Symptom Distress, Biologic Correlates of Inflammatory Response in Patients with Chronic Graft Versus Host Disease (in development |
